S. Rubio-Mediavilla

发表

Lack of Adrenomedullin Aggravates Acute TNBS-Induced Colitis Symptoms in Mice, Especially in Females

Alfredo Martínez, I. Larráyoz, J. Narro-Íñiguez, 2017, Front. Physiol..

Maraviroc improves hepatic triglyceride content but not inflammation in a murine nonalcoholic fatty liver disease model induced by a chronic exposure to high‐fat diet

J. Blanco, J. Oteo, L. Ochoa-Callejero, 2018, Translational research : the journal of laboratory and clinical medicine.

Maraviroc , a CCR 5 antagonist , ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease ( NAFLD )

J. Aguilera-Lizarraga, J. Blanco, P. Pérez-Matute, 2014 .

Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD).

J. Aguilera-Lizarraga, J. Blanco, P. Pérez-Matute, 2014, The Journal of antimicrobial chemotherapy.

Intravascular large B cell lymphoma.

R. García‐Muñoz, P. Rabasa, S. Rubio-Mediavilla, 2014, Leukemia research reports.

Prognostic and Predictive Biomarkers in Patients with Locally Advanced Rectal Cancer (LARC) Treated with Preoperative Chemoradiotherapy

I. Larráyoz, E. Ramalle-Gómara, Alfredo Martínez, 2022, Journal of clinical medicine.

Glu-tubulin is a marker for Schwann cells and can distinguish between schwannomas and neurofibromas

Alfredo Martínez, J. García-Sanmartín, S. Rubio-Mediavilla, 2016, Histochemistry and Cell Biology.

Implications of maraviroc and/or rapamycin in a mouse model of fragility

A. Carnero, J. Blanco, J. Oteo, 2020, Aging.

Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model

J. Blanco, Alfredo Martínez, J. Oteo, 2013, PloS one.

Small molecules related to adrenomedullin reduce tumor burden in a mouse model of colitis-associated colon cancer

Alfredo Martínez, L. Ochoa-Callejero, J. García-Sanmartín, 2017, Scientific Reports.

Expression of Mitochondrial Long Non-Coding RNAs, MDL1 and MDL1AS, Are Good Prognostic and/or Diagnostic Biomarkers for Several Cancers, Including Colorectal Cancer

I. Larráyoz, Alfredo Martínez, J. Narro-Íñiguez, 2024, Cancers.

Role of maraviroc and/or rapamycin in the liver of IL10 KO mice with frailty syndrome

A. Carnero, E. Verdugo-Sivianes, S. Muñoz-Galván, 2024, PloS one.